Attorneys for parents and Abbott Laboratories faced off during opening arguments Monday in the first Chicago trial over ...

The latest chapter in an ongoing legal battle between Abbott Laboratories and parents of babies born prematurely is slated to ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Abbott Laboratories (NYSE:ABT) ...

"Boring" may be just what the doctor ordered in this volatile market.

Abbott Laboratories’ modelled fair value has been adjusted only fractionally, from US$133.39 to US$133.33 per share, keeping the core price target effectively stable in absolute terms. That tiny shift ...

Exact Sciences Corp. (NASDAQ:EXAS) is one of 15 stocks with the biggest hedge fund momentum, after gaining 31 hedge fund holders during the fourth quarter of 2025. On February 20, the company ...

Jury selection in Cook County is set to kick off this week in a closely watched courtroom battle over Abbott Laboratories’ ...

Monday - Friday, 6:00 - 7:00 PM ET CNBC's Jim Cramer on Friday evaluated the stock of Abbott Laboratories, a healthcare company that's been weighed down by ongoing litigation for several months.

This company has delivered earnings and dividend growth over time. Abbott’s innovation and a new acquisition could spur more growth in the years to come. 10 stocks we like better than Abbott ...

Abbott Laboratories Inc. defeated a proposed class action alleging it disclosed the protected health data of consumers to ...

Abbott Laboratories (NYSE:ABT) on Wednesday reported first-quarter sales of $10.36 billion, up 7.2% year over year, almost in line with the consensus of $10.40 billion. First-quarter sales increased 4 ...

You may not immediately recognize the name Abbott Laboratories (NYSE: ABT), but you've probably come into close contact with one of the company's many products -- from a coronavirus test to Ensure ...